Cargando…

Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder

For a long time, Substance Use Disorders (SUDs) were not considered a component in the etiology of dementia. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders introduced substance-induced neurocognitive disorders, incorporating this notion to clinical practice. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Requena-Ocaña, Nerea, Araos, Pedro, Serrano-Castro, Pedro J., Flores-López, María, García-Marchena, Nuria, Oliver-Martos, Begoña, Ruiz, Juan Jesús, Gavito, Ana, Pavón, Francisco Javier, Serrano, Antonia, Mayoral, Fermín, Suarez, Juan, de Fonseca, Fernando Rodríguez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866623/ https://www.ncbi.nlm.nih.gov/pubmed/36674698 http://dx.doi.org/10.3390/ijms24021183

Ejemplares similares

Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder
por: Requena-Ocaña, Nerea, et al.
Publicado: (2021)

Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder
por: Herrera-Imbroda, Jesús, et al.
Publicado: (2023)

Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients
por: Herrera-Imbroda, Jesús, et al.
Publicado: (2023)

Influence of gender and education on cocaine users in an outpatient cohort in Spain
por: Requena-Ocaña, Nerea, et al.
Publicado: (2021)

Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder
por: Galván, Sandra Torres, et al.
Publicado: (2021)

Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder
por: Requena-Ocaña, Nerea, et al.
Publicado: (2022)

Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder
por: Requena-Ocaña, Nerea, et al.
Publicado: (2023)

Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients
por: García-Marchena, Nuria, et al.
Publicado: (2020)

Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders
por: Flores-López, María, et al.
Publicado: (2022)

Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders
por: Flores-López, María, et al.
Publicado: (2023)

Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex
por: García-Marchena, Nuria, et al.
Publicado: (2022)

Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease
por: Flores-López, María, et al.
Publicado: (2021)

Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapy
por: Romero-Sanchiz, Pablo, et al.
Publicado: (2020)

Sex Differences in Psychiatric Comorbidity and Plasma Biomarkers for Cocaine Addiction in Abstinent Cocaine-Addicted Subjects in Outpatient Settings
por: Pedraz, María, et al.
Publicado: (2015)

Repeated Restraint Stress and Binge Alcohol during Adolescence Induce Long-Term Effects on Anxiety-like Behavior and the Expression of the Endocannabinoid System in Male Rats
por: Sánchez-Marín, Laura, et al.
Publicado: (2022)

Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders
por: García-Marchena, Nuria, et al.
Publicado: (2019)

Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients
por: Araos, Pedro, et al.
Publicado: (2019)

Higher Impulsivity As a Distinctive Trait of Severe Cocaine Addiction among Individuals Treated for Cocaine or Alcohol Use Disorders
por: García-Marchena, Nuria, et al.
Publicado: (2018)

Plasma Chemokines in Patients with Alcohol Use Disorders: Association of CCL11 (Eotaxin-1) with Psychiatric Comorbidity
por: García-Marchena, Nuria, et al.
Publicado: (2017)

Effects of Intermittent Alcohol Exposure on Emotion and Cognition: A Potential Role for the Endogenous Cannabinoid System and Neuroinflammation
por: Sanchez-Marin, Laura, et al.
Publicado: (2017)

Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders
por: García-Marchena, Nuria, et al.
Publicado: (2017)

Oleoylethanolamide Modulates BDNF-ERK Signaling and Neurogenesis in the Hippocampi of Rats Exposed to Δ(9)-THC and Ethanol Binge Drinking During Adolescence
por: Silva-Peña, Daniel, et al.
Publicado: (2019)

Clinical Value of Inflammatory and Neurotrophic Biomarkers in Bipolar Disorder: A Systematic Review and Meta-Analysis
por: Vega-Núñez, Amanda, et al.
Publicado: (2022)

Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice
por: Vida, Margarita, et al.
Publicado: (2015)

Chronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese Mice
por: Gavito, Ana Luisa, et al.
Publicado: (2016)

Plasma Concentrations of BDNF and IGF-1 in Abstinent Cocaine Users with High Prevalence of Substance Use Disorders: Relationship to Psychiatric Comorbidity
por: Pedraz, María, et al.
Publicado: (2015)

Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFα) as a potential biomarker of consumption and dual diagnosis
por: Maza-Quiroga, Rosa, et al.
Publicado: (2017)

CB(1) Blockade Potentiates Down-Regulation of Lipogenic Gene Expression in Perirenal Adipose Tissue in High Carbohydrate Diet-Induced Obesity
por: Vida, Margarita, et al.
Publicado: (2014)

Factors associated with use of community mental health services by schizophrenia patients using multilevel analysis
por: Moreno-Küstner, Berta, et al.
Publicado: (2011)

The adiponectin promoter activator NP-1 induces high levels of circulating TNFα and weight loss in obese (fa/fa) Zucker rats
por: Decara, Juan, et al.
Publicado: (2018)

Treatment with a novel oleic-acid–dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats
por: Decara, Juan M., et al.
Publicado: (2015)

Pharmacokinetics and Endocrine Effects of an Oral Dose of D-Pinitol in Human Fasting Healthy Volunteers
por: Navarro, Juan A., et al.
Publicado: (2022)

Sudden cessation of fluoxetine before alcohol drinking reinstatement alters microglial morphology and TLR4/inflammatory neuroadaptation in the rat brain
por: Aranda, Jesús, et al.
Publicado: (2021)

Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats
por: Pavón, Francisco Javier, et al.
Publicado: (2016)

Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
por: Decara, Juan, et al.
Publicado: (2020)

Localization of peroxisome proliferator-activated receptor alpha (PPARα) and N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus
por: Rivera, Patricia, et al.
Publicado: (2014)

Environmental Enrichment, Age, and PPARα Interact to Regulate Proliferation in Neurogenic Niches
por: Pérez-Martín, Margarita, et al.
Publicado: (2016)

Computational and Biological Evaluation of N-octadecyl-N′-propylsulfamide, a Selective PPARα Agonist Structurally Related to N-acylethanolamines
por: Moreno-Santos, Inmaculada, et al.
Publicado: (2014)

Pharmacological Administration of the Isoflavone Daidzein Enhances Cell Proliferation and Reduces High Fat Diet-Induced Apoptosis and Gliosis in the Rat Hippocampus
por: Rivera, Patricia, et al.
Publicado: (2013)

The evaluation of serum brain‐derived neurotrophic factor and neurofilament light chain levels in patients with obstructive sleep apnea syndrome
por: Arslan, Burak, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9jvdmflgm8boqe3delb69prh0t